BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8218780)

  • 1. [Detection and clinical course of metabolic multiple vascular risk syndrome].
    de Portugal Alvarez J; del Rivero JP; Sánchez Rodríguez A; Chimpen Ruiz V
    An Med Interna; 1993 Aug; 10(8):369-76. PubMed ID: 8218780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Profile of cardiovascular risk factors in females with a definitive myocardial infarct up to 49 years of age].
    Stammberger K; Schneider G
    Z Gesamte Inn Med; 1989 Mar; 44(6):177-9. PubMed ID: 2728560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiologic principles of metabolic syndrome. Consequences for early diagnosis and prevention].
    Häring HU
    Fortschr Med; 1992 Dec; 110(34):633-6. PubMed ID: 1483614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
    Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
    Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension, Type II diabetes mellitus and macroangiopathy: risk factors and their association].
    Eggenberger M
    Schweiz Rundsch Med Prax; 1994 Feb; 83(5):123-8. PubMed ID: 8122058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome.
    Mardarowicz G; Lopatyński J; Nicer T
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):426-31. PubMed ID: 15315027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tophaceous gout in plurimetabolic syndrome].
    Iannello S; Cavaliere G; Ferro G; Giuffrì MV; Impellizzieri D; Incognito C; Lizzio G; Neri S; Rapisarda A; Belfiore F
    Minerva Med; 1998; 89(11-12):419-37. PubMed ID: 10212666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome' in a middle-aged Finnish population.
    Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Takala JK
    J Cardiovasc Risk; 1997 Aug; 4(4):291-5. PubMed ID: 9477208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
    Giovannucci E; Michaud D
    Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing heart failure in patients with diabetes.
    Srikanthan P; Hsueh W
    Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the metabolic syndrome in military and civilian flying personnel.
    Kalff KG; Maya-Pelzer P; Andexer A; Deuber HJ
    Aviat Space Environ Med; 1999 Dec; 70(12):1223-6. PubMed ID: 10596780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How should we implement the basic principles of treatment of type 2 diabetes mellitus from the aspect of the hormono-metabolic syndrome X (5H)?].
    Hrnciar J; Jakubíková K; Okapcová J
    Vnitr Lek; 1992 Aug; 38(8):729-37. PubMed ID: 1455753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance and hyperinsulinemia--clinical aspects].
    Kozek E
    Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial infarct in type II diabetes].
    Chlumský J; Krivohlavý A; Lomícek M
    Vnitr Lek; 1993 Mar; 39(3):224-8. PubMed ID: 8506672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.
    Clavijo LC; Pinto TL; Kuchulakanti PK; Torguson R; Chu WW; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2006; 7(1):7-11. PubMed ID: 16513517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on the risk factors of cerebral infarction as complication of type 2 diabetes mellitu patients].
    Meng Q; Wang J; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):208-11. PubMed ID: 11860880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.